慢性静脉功能不全的EVLA、NBCA与RFA远期疗效
一项单中心回顾性研究纳入232例慢性静脉功能不全患者,比较EVLA、NBCA与RFA的远期疗效。平均随访67.5±4.7个月,RFA在3年和5年随访时闭塞成功率显著优于EVLA,NBCA与RFA远期成功相似;EVLA并发症和疼痛评分更高且恢复日常活动更慢,NBCA手术时间最短。
要点
- RFA在3年和5年随访时闭塞成功率显著优于EVLA。
- NBCA与RFA的远期成功相似,NBCA手术时间显著短于其他两术式。
- EVLA并发症发生率、疼痛评分更高,恢复日常活动时间更长。
核心结论
- 三种术式术后早期闭塞成功率相似,但RFA在3年和5年随访时成功率显著高于EVLA。
- NBCA与RFA远期成功相似,NBCA手术时间显著更短,EVLA并发症和疼痛更多且恢复更慢。
研究设计与样本
- 单中心回顾性研究,纳入2014年1月1日至2017年1月1日接受EVLA、NBCA或RFA治疗慢性静脉功能不全的患者232例。
主要发现
- EVLA组77例,NBCA组73例,RFA组82例;平均随访67.5±4.7个月。
- 手术时间NBCA组13.5分钟,显著短于EVLA组31.7分钟和RFA组27.9分钟(P=.001)。
- EVLA组疼痛评分最高(P=.001),并发症发生率更高且恢复日常活动时间更长(P=.001)。
- 术后第1天及6、12、24个月三组闭塞成功率相当;3年和5年随访时RFA显著优于EVLA(P=.024和P=.011)。
- NBCA与RFA在3年和5年随访时成功相似(P=.123和P=.330)。
临床怎么用
- 对于慢性静脉功能不全,RFA在远期闭塞成功率上可能优于EVLA,NBCA与RFA远期效果相当且手术时间更短。
- EVLA与更高的疼痛评分、并发症发生率和更长的恢复日常活动时间相关,选择术式时需权衡。
局限性
- 本研究为单中心回顾性研究,可能存在选择偏倚和混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the present retrospective, single-center study, we evaluated the long-term effectiveness and reliability of endovenous laser ablation (EVLA), endovenous n-butyl cyanoacrylate (NBCA) application, and radiofrequency ablation (RFA) in the management of chronic venous insufficiency (CVI). METHODS: The medical records of patients who had undergone EVLA, NBCA, or RFA for CVI from January 1, 2014 to January 1, 2017 were reviewed. The medical records included data on sex, age, body mass index, American Society of Anesthesiologists score, and symptoms at admission. The great saphenous vein diameter, CEAP (Clinical, Etiology, Anatomy, and Pathophysiology) classification, and venous clinical severity score were also recorded. All the patients were followed up with physical examinations and color Doppler ultrasound scan at the first week and 6 and 12 months after treatment. After 12 months, the follow-up examinations were performed annually. RESULTS: A total of 232 patients who had undergone lower limb CVI surgical treatment (EVLA, n = 77; NBCA, n = 73; RFA, n = 82). The mean follow-up time was 67.5 ± 4.7 months. The procedure duration was significantly shorter for the NBCA group (13.5 minutes) vs that for the EVLA (31.7 minutes) and RFA (27.9 minutes) groups (P = .001). The pain score was highest in the EVLA group (P = .001). The EVLA group had also experienced a significantly greater incidence of complications and a longer time to return to daily activities (P = .001). The post hoc analysis revealed comparable occlusion success among the three groups on the first postoperative day and at 6, 12, and 24 months postoperatively. However, significantly better occlusion rates were found for RFA vs EVLA at 3 and 5 years of follow-up (P = .024 and P = .011, respectively). The success of NBCA and RFA was similar at 3 and 5 years of follow-up (P = .123 and P = .330, respectively). CONCLUSIONS: The outcomes showed similar early postoperative occlusion success among all three CVI treatment techniques. However, RFA resulted in a significantly higher success rate compared with EVLA at 3 and 5 years of follow-up. Additionally, the NBCA and RFA procedures achieved comparable long-term success. However, EVLA was associated with significantly greater complication rates and pain scores and a longer time to return to daily activities. The NBCA procedure had a significantly shorter operation time compared with the other procedures.
引用
- El Kilic H, Bektas N, Bitargil M, et al. Long-term outcomes of endovenous laser ablation, n-butyl cyanoacrylate, and radiofrequency ablation for treatment of chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34688972. doi:10.1016/j.jvsv.2021.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。